Brightside Health provides safe and effective mental health care, for individuals with varying levels of depression, anxiety, and other mood disorders, up to those with suicidal intent.

Ginger is proven to help people get better by providing on-demand coaching, teletherapy, telepsychiatry and guided self-care - right through a smartphone. Within seconds, members have access to a behavioral health coach - 24/7, 365 days a year. Within 48 hours, members can also get a virtual appointment with our therapists and psychiatrists. Ginger is the only behavioral health provider that continuously uses AI & machine learning to improve both access to and quality of care for anyone managing symptoms of stress, anxiety, depression or more complex challenges. Our AI technology has been recognized by the World Economic Forum as a Technology Pioneer, and we were recognized as one of the top 10 Most Innovative Companies in Healthcare by Fast Company. Leading employers, such as BuzzFeed, Sephora, Pinterest and Chegg, trust Ginger to provide instant access to complete care for all their employees.

Headspace Health is a leading provider of mental health and wellbeing solutions, touching the lives of over 100 million people in 190 countries. Through our flagship Headspace brand, we provide mindfulness tools for everyday life, including meditations, sleepcasts, mindful movement, and focus exercises. Our enterprise brands, Headspace for Work and Ginger, are distributed through over 3,500 enterprises, including Starbucks, Adobe, Delta Air Lines, and Paramount; and through health plans such as Cigna. Our members and enterprise partners’ employees have access to mindfulness and meditation tools, CBT, coaching, therapy, and psychiatry, ultimately helping them to be healthier and more productive. To learn more about Headspace Health and our family of brands, visit www.headspacehealth.com.

Brightside has developed a purpose-built EHR that incorporates anytime messaging, best practices, advanced workflow, risk assessment, strong security protocols, and clinical decision support to help providers effeciently and securely practice to the top of their license.

At Brightside Health, we have developed innovative solutions that address the full spectrum of mental health needs, particularly for underserved and high-severity populations. Our comprehensive telepsychiatry platform seamlessly integrates with health plans, hospitals, and referral networks, delivering accessible, high-quality care tailored to conditions ranging from mild to severe, including elevated suicide risk and substance use disorders.

Our comprehensive platform stands out as the only telemental health provider specifically designed to treat complex, hard-to-manage cases, offering appointments within 24 hours. Our tiered levels of care enhance this approach by directing individuals with positive suicidal ideation screens to our Suicide Prevention Program for rapid referrals, reducing emergency department admissions and readmissions.

In line with our commitment to supporting high-risk populations, Brightside serves teens and collaborates with Medicaid, Medicare, and Exchange plans to ensure that care reaches those who need it most. Our partner-focused reporting includes closed-loop outcomes data to drive optimal revenue, customized dashboards for enhanced visibility, and supplemental data files that bridge quality gaps and support holistic patient care.

Among our proprietary innovations is PrecisionRx, a groundbreaking tool that analyzes hundreds of individual data points to recommend medications with the highest likelihood of effectiveness and tolerance. This clinical decision support tool allows our providers to optimize medication choices from the outset, resulting in a 70% response rate for first-cycle treatments—double the industry standard. Additionally, we leverage AI-driven tools to streamline remote patient monitoring, risk assessment, and both patient and clinical workflows, enhancing provider efficiency, reducing burnout, and enabling our clinicians to focus on delivering high-quality, personalized care.

We are also committed to peer-reviewed research, having published 12 studies to date. Example results include:  

• A study in BMC Psychiatry showed that 86% of patients using PrecisionRx with remote monitoring achieved clinically significant improvement at 12 weeks, and 71% reached remission, underscoring the tool’s effectiveness in improving patient outcomes.
• Research published in Cureus revealed that nearly 80% of patients on Brightside Health’s platform experienced a meaningful reduction in symptoms, compared to 52% of those receiving treatment as usual, highlighting the effectiveness of Brightside Health’s care model. 
• Brightside Health’s latest research, published in JMIR Mental Health, demonstrated that OpenAI’s GPT-4 can predict mental health crises with similar accuracy to trained clinicians, but with higher sensitivity and lower specificity. This highlights the potential of AI to enhance clinical decision making and improve the speed and quality of care and reinforces Brightside Health’s approach to leveraging AI and data to deliver more effective mental health treatment. 
• In JMIR Formative Research, Brightside Health examined results from over 8,500 U.S.-based adults who either received at least 12 weeks of treatment, or engaged on our platform without receiving care. Among participants, those receiving care through Brightside Health’s Suicide Prevention Program were 4.3 times more likely to experience remission than the control group.